CONSHOHOCKEN, Pa., March 29, 2016 -- Symphony Health Solutions, a provider of high-value health data, analytics, technology and consulting solutions for life science manufacturers, researchers, payers and providers, today introduced PHAST™ PayerRx, the latest audit in the next generation PHAST Powered by IDV® online market analytics solution. PHAST PayerRx reveals national level market access dynamics via a visually-rich, intuitive solution. The new audit evaluates prescription performance at the payer level by segmenting all retail, mail order, and specialty prescriptions filled in the US by the managed care organization or pharmacy benefit manager that ultimately paid for the prescription. This view rapidly delivers key brand insights, such as the top plans contributing to brand growth, share of brand within plans, market access dynamics for a brand relative to competitors within specific national level plans, and how payment type impacts prescribing based on physician specialty.
“We saw a need for a solution that would give clients rapid insight into payer access dynamics at the national level. Our existing managed care audit, PHAST Payer, gets into the detailed “why” of what is causing certain payment type trends within a brand, but clients wanted a way to quickly take a pulse of their payer landscape to see “what” was occurring within an MCO or PBM,” said Derek J. Evans, SVP, Product Management. For example, PHAST PayerRx was used to look at how top MCOs for a company’s newly launched brand might be impacting growth. In one quick report, the audit revealed that the top three MCOs were driving one-third of total Rx volume, but that declines occurred in two of those three in the months shortly after launch. This information provided rapid directional insight to assist business development teams, financial analysts and brand teams to effectively evaluate business opportunities.
PHAST PayerRx, the latest complementary audit to PHAST Payer and PHAST Prescription Monthly, includes projected retail and mail order prescriptions as well as attributes for primary payer with MCO and PBM details including plan type and payment type. PHAST PayerRx offers the fastest monthly data refreshes available on the market today allowing timely action and decision making.
The PHAST Powered by IDV® suite of audits leverages the industry’s largest sample of retail prescription sales and claims data to give brand managers, marketers, and financial analysts a cutting-edge business intelligence tool for market research, business development and sales forecasting. All PHAST modules come with access to a visual insights solution, where users can view pre-built reports and dashboards, or create customized dashboards to provide at-a-glance visualizations of the data and attributes that are most important to them. As with all of PHAST’s reporting solutions, PHAST PayerRx is updated automatically with each new refresh of the data.
PHAST PayerRx is available immediately as an annual subscription. For more information, visit the Symphony Health Solutions website at www.symphonyhealth.com.
About Symphony Health Solutions
Symphony Health Solutions provides best-in-class data, analytics, technology, and consulting solutions with actionable insights. The company helps clients grow while enabling a transformation of the healthcare ecosystem by connecting and integrating a broad set of primary and secondary sources, health research, analytics and consulting. Symphony delivers a comprehensive perspective on the real dynamics that drive business in the life sciences market. For more information, visit www.symphonyhealth.com.
For media information, please contact: Heather Varela, Symphony Health Solutions [email protected] +1 602.463.7838


Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs 



